Cost-effectiveness of influenza vaccination in high-risk children in Argentina

Vaccine

Volumn 19, Issue 30, 2001, Pages 4204-4213

  Dayan, Gustavo H ^a,e   Nguyen, Van Hung ^b   Debbag, Roberto ^a   Gómez, Roberto ^c   Wood, Susan C ^d  

^a Fundacion Centro de Estudios Infectologicos   (Argentina)

^b Gouvernement du Quebec   (Canada)

^c Aventis Pasteur   (Argentina)

^d Biogen Idec France   (France)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cost effectiveness; Influenza; Vaccination

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE; PARACETAMOL;

ADOLESCENT; ARGENTINA; ARTICLE; CHILD; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFANT; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; OUTPATIENT CARE; PERSONNEL MANAGEMENT; PRIORITY JOURNAL; SIDE EFFECT;

ADOLESCENT; ARGENTINA; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; INCIDENCE; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; RISK; VACCINATION;

EID: 0035919611     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00160-8     Document Type: Article

References (76)

1. Influenza viruses
2. Influenza in children: Relationship to other respiratory agents
3. Impact of type A influenza on children: A retrospective study
4. Association of respiratory viral infections with cystic fibrosis
5. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices
6. Influenza immunization polices in Europe and the United States
7. Consenso sobre actualidad en vacunas
8. Congenital heart disease: Prevalence at livebirth
9. Congenital heart disease in 56 109 births
10. Congenital heart disease among 160 480 liveborn children in Liverpool 1960 to 1969
11. Some epidemiological aspects of congenital heart disease in Denmark
12. Prevalence of asthma symptoms in Latin America: The international study of asthma and allergies in childhood (ISAAC)
13. Diabetes mellitus: Incidence, prevalence, survivorship, and cause of death in Rochester, MN, 1945-1970
14. Prevalence of diabetes in Michigan school-age children
15. Comparison of US inactivated split-virus and Russian live, attenuated cold-adapted trivalent influenza vaccine in Russian schoolchildren
16. Live attenuated and inactivated influenza vaccine in school-age children
17. Influenza vaccine: A reappraisal of their use
18. Inactivated influenza virus vaccines: Past, present, and future
19. Influenza immunoprophylaxis after 30 years' experience
20. Viral respiratory disease at Lowry Air Force Base in Denver, 1952-82
21. Evaluation de l'efficacite du vaccin grippal 1995 dans une unite militaire de la region Ile-de-France
22. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases
23. Vaccination against influenza in children with acute lymphoblastic leukemia
24. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B
25. Studies on inactivated influenza vaccines II. Effect of increasing dosage on antibody response and adverse reactions in man
26. Influenza
27. Infuenza virus infections in Seattle families, 1975-1979
28. Estimates of the US health impact of influenza
29. Estimation of the efficacy of live, attenuated influenza vaccine from a 2-year, multi-center vaccine trial: Implications for influenza epidemic control
30. Current estimates from the National Health Interview Survey, 1994. National Center for Health Statistics
31. Current estimates from the National Health Interview Survey, 1995. National Center for Health Statistics
32. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics
33. A perspective on the significance of pandemic influenza
34. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion
35. Consenso sobre infecciones en pediatría ambulatoria
36. Consideration of the risk of influenza in children and indications for prophylaxis
37. Influenza type A and B infections in hospitalized pediatric patients. Who should be immunized?
38. Economic impact of influenza vaccination in preschool children
39. Potential cost savings attribuable to influenza vaccination in school-aged children
40. Serious morbidity and mortality associated with influenza epidemics
41. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza
42. Impact of influenza virus infection as a cause of pediatric hospitalization
43. Influenza A and B virus infection in infants and young children during the years 1957-1976
44. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine
45. A randomized controlled trial of cold adapted and inactivated vaccines for the prevention of influenza A disease
46. Natural or vaccine-induced antibody on a predictor of immunity in the face of natural challenge with influenza viruses
47. Trials of influenza A/New Jersey/76 virus vaccines in normal children: An overview of age-related antigenicity and reactogenicity
48. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children- a multicentered evaluation of dosage and safety
49. The effectiveness of vaccination against influenza in healthy working adults
50. Effectiveness and cost-benefit of an influenza vaccination program for health care workers
51. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
52. The costs and benefits of preventing influenza in Ontario's elderly
53. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families
54. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature
55. The efficacy of influenza vaccination in elderly individuals: A randomized double-blind placebo-controlled trial
56. Influenza vaccination in the prevention of acute otitis media in children
57. Influenza A vaccine decreases the incidence of otitis in 6- to 30-month-old children in day care
58. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children
59. Influenza-A infection in children
60. Children hospitalized with influenza B infection
61. Type A2 influenza viral infections in children
62. Critical influenza virus infection
63. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
64. How to calculate indirect costs in economic evaluations
65. A practical guide for calculating indirect costs of disease
66. Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccine in high risk children